Cancer drug prices remain unchanged from November 9, 2026, with Keytruda at Rs 2.16 lakh and Alecensa at Rs 4.3 lakh, despite trade margin regulations.
No price relief for Cancer patients as NPPA list shows no change in key drug MRPs
- Post author:pracheeshofficial@gmail.com
- Post published:29/10/2026
- Post category:DAILY UPDATES
- Post comments:0 Comments
